Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Fact.mr
www.factmr.com/

Bookmark and Share
Anaphylaxis Treatment Market Trends, Regulations And Competitive Landscape Outlook to 2028
Fact.MR has announced the addition of the “ Anaphylaxis Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

BriefingWire.com, 4/17/2019 - The type of severe allergic reaction which may cause due to food, insect bites, latex or medications is known as anaphylaxis. Anaphylaxis is fast in the beginning and cause serious health problems and sometimes death. The symptoms of anaphylaxis include itchy rashes, vomiting, breath shortness, tongue or throat swelling, low blood pressure, and lightheadedness. These all symptoms may last for a minute to an hour and may typically come on over and over again. The mechanism comprises of the release of mediators by either non-immunologic or immunologic mechanism from certain types of white blood cells activated. The primary anaphylaxis treatment includes epinephrine, steroids, and antihistamines through an oral or parenteral route of transmission. An additional dosage of epinephrine may require in some cases. Approximately 2% of the world population is expected to experience anaphylaxis at some point in life, globally. Worldwide the rates of anaphylaxis are increasing and mostly occurs in young population and females. In the United States, the percentage of the population admitted in the hospitals is very high and increasing and around 0.3% of the population die due to anaphylaxis.

Anaphylaxis Treatment: Market Dynamics

The increasing incidence of anaphylaxis globally is the main driving factor for the growth of the anaphylaxis treatment market. Additionally, innovative novel product launches by the major manufacturers contributing to the market growth of the anaphylaxis treatment market. For eg: in November 2018, Teva Pharmaceuticals, Inc. received FDA approval for epinephrine an auto-injector. It is the first generic equivalent to EpiPen, an emergency injectable anaphylaxis treatment. Increasing awareness regarding available anaphylaxis treatment options among patients and healthcare professionals are the boosting factors for the growth of the anaphylaxis treatment market. However, anaphylaxis treatment cost, lack of awareness in developing regions about the allergies and anaphylaxis treatment hampering the growth of anaphylaxis market. Moreover, side effects related to drugs used in the anaphylaxis treatment is expected to hinder the growth of the anaphylaxis treatment market.

Request Free Sample Report@ www.factmr.com/connectus/sample?flag=S&rep_id=3417

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2019 Proserve Technology, Inc.